Immunomic Therapeutics
Lancaster
About Immunomic Therapeutics
Immunomic Therapeutics is a development stage biotechnology company that develops lysosomal associated membrane protein-based vaccines for the treatment of allergy and other human health targets. The company was founded in 2005 and is based in Lancaster, Pennsylvania.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $84.9M
- Last round: Series Unknown (Jun 2025)
- Website: immunomix.com
- Phone: 717-327-1919
Industries & Categories
Biotechnology, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/immunomic-therapeutics-78863 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.